We are live on ! Find out more
Beck Mack & Oliver

Beck Mack & Oliver Portfolio holdings

AUM $5.02B Turnover 8.21%
1-Year Est. Return 3.96%
 

Beck Mack + Oliver is a partner-owned investment firm, founded in 1931, that holds a concentrated portfolio of 20 to 25 businesses for the long term. It looks for companies that earn high returns on capital, then waits for a price that sits well below its estimate of their value, and trades little. Its team of eight portfolio managers runs individually managed portfolios and the Beck Mack + Oliver Partners Fund, an open-end mutual fund.

This Fund
S&P 500
This Quarter Est. Return
+1.09%
1 Year Est. Return
+3.96%
3 Year Est. Return
+67.81%
5 Year Est. Return
+87.26%
10 Year Est. Return
+364.19%
AUM
$5.02B
AUM Growth
-$113M
Cap. Flow
-$107M
Cap. Flow %
-2.14%
Top 10 Hldgs %
45.74%
Holding
207
New
6
Increased
31
Reduced
81
Closed
11
Avg Time Held
7.5 years
Top 10 Avg Time Held
4.9 years
Top 20 Avg Time Held
4.9 years

Top Buys

Rank Stock Value
1
SGI icon
Somnigroup International
SGI
+$31.2M
2
WMB icon
Williams Companies
WMB
+$16.3M
3
ALC icon
Alcon
ALC
+$12.3M
4
SHC icon
Sotera Health
SHC
+$8.39M
5
ARES icon
Ares Management
ARES
+$6.77M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$21.1M
2
CSGP icon
CoStar Group
CSGP
+$19.1M
3
APO icon
Apollo Global Management
APO
+$14.6M
4
RDNT icon
RadNet
RDNT
+$11.7M
5
BWIN icon
Baldwin Insurance Group
BWIN
+$11.6M

Sector Composition

Rank Sector Weight
1 Financials 33.43%
2 Healthcare 18.28%
3 Industrials 14.15%
4 Communication Services 9.38%
5 Consumer Discretionary 8.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
JPM.PRC icon
151
JPMorgan Chase 6.00% Series EE Preferred Stock
JPM.PRC
$1.63B
$325K 0.01%
14,312
– –
2019 Q2
29 quarters
MCD icon
152
McDonald's
MCD
$193B
$323K 0.01%
1,400
+200
+17% +$52.6K
2013 Q2
53 quarters
TSLA icon
153
Tesla
TSLA
$1.52T
$319K 0.01%
900
– –
2025 Q2
5 quarters
LGND icon
154
Ligand Pharmaceuticals
LGND
$5.98B
$317K 0.01%
1,015
-299
-23% -$88.4K
2026 Q1
2 quarters
SCHM icon
155
Schwab US Mid-Cap ETF
SCHM
$14.6B
$312K 0.01%
9,167
– –
2024 Q2
9 quarters
ELV icon
156
Elevance Health
ELV
$93.8B
$311K 0.01%
799
– –
2023 Q4
11 quarters
LOAR icon
157
Loar Holdings
LOAR
$6.83B
$308K 0.01%
5,000
-22,000
-81% -$1.55M
2024 Q2
9 quarters
SCHV icon
158
Schwab US Large-Cap Value ETF
SCHV
$15.3B
$304K 0.01%
9,134
– –
2023 Q3
12 quarters
J icon
159
Jacobs Solutions
J
$18.5B
$302K 0.01%
2,232
– –
2024 Q1
10 quarters
SPGI icon
160
S&P Global
SPGI
$129B
$302K 0.01%
765
– –
2024 Q4
7 quarters
IDXX icon
161
Idexx Laboratories
IDXX
$54.4B
$300K 0.01%
575
– –
2016 Q1
42 quarters
WFC icon
162
Wells Fargo
WFC
$243B
$295K 0.01%
3,682
– –
2024 Q4
7 quarters
ARM icon
163
Arm
ARM
$196B
$290K 0.01%
1,000
– –
2026 Q2
1 quarter
OTIS icon
164
Otis Worldwide
OTIS
$29.6B
$284K 0.01%
4,422
-160
-3% -$11.4K
2020 Q2
25 quarters
SO icon
165
Southern Company
SO
$109B
$282K 0.01%
3,400
– –
2013 Q2
53 quarters
MPC icon
166
Marathon Petroleum
MPC
$102B
$277K 0.01%
+700
New +$242K
2026 Q3
0 quarters
AB icon
167
AllianceBernstein
AB
$2.96B
$267K 0.01%
7,658
– –
2021 Q2
21 quarters
AMGN icon
168
Amgen
AMGN
$240B
$261K 0.01%
619
– –
2023 Q4
11 quarters
CMI icon
169
Cummins
CMI
$58.5B
$258K 0.01%
500
-20
-4% -$12.1K
2025 Q3
4 quarters
NUE icon
170
Nucor
NUE
$56.3B
$257K 0.01%
1,100
– –
2026 Q2
1 quarter
INTC icon
171
Intel
INTC
$291B
$253K 0.01%
2,108
+100
+5% +$10.2K
2025 Q3
4 quarters
KMI icon
172
Kinder Morgan
KMI
$69.9B
$243K ﹤0.01%
8,050
– –
2026 Q1
2 quarters
VB icon
173
Vanguard Morningstar Small-Cap ETF
VB
$76.9B
$236K ﹤0.01%
830
– –
2020 Q2
25 quarters
TD icon
174
Toronto Dominion Bank
TD
$189B
$235K ﹤0.01%
2,000
– –
2026 Q2
1 quarter
ACN icon
175
Accenture
ACN
$134B
$233K ﹤0.01%
+1,270
New +$215K
2026 Q3
0 quarters

Similar funds

Beck Mack & Oliver's Q3 2026 Portfolio in Review

As of Q3 2026, Beck Mack & Oliver held 207 positions worth $5.02B, down 2.2% from $5.13B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Beck Mack & Oliver's Q3 2026 filing shows 6 new, 31 increased, 81 reduced and 11 closed positions. Its largest new stake was Medline: 122,330 shares worth $4.24M. The largest sale was Apple, an estimated $21.1M.

By sector, the portfolio is most concentrated in Financials at 33% of assets, down from 35% a quarter earlier, followed by Healthcare and Industrials.

  • Beck Mack & Oliver's largest Q3 2026 buy was Medline: 122,330 shares worth $4.24M.
  • Beck Mack & Oliver added most to Somnigroup International in Q3 2026, an estimated $31.2M increase.
  • Beck Mack & Oliver's biggest Q3 2026 reduction was Apple, cutting an estimated $21.1M.
  • Beck Mack & Oliver fully exited Baldwin Insurance Group in Q3 2026, selling an estimated $11.6M.
  • Beck Mack & Oliver's ten largest holdings make up 46% of its $5.02B portfolio in Q3 2026.
  • Beck Mack & Oliver opened 6 new positions and closed 11 in Q3 2026.
  • Beck Mack & Oliver's portfolio value fell 2.2% quarter-over-quarter to $5.02B.

Based on Beck Mack & Oliver's 13F filing for Q3 2026, filed 16 Nov 2026.